Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia
Monika Podhorecka(Medical University of Lublin), Zbigniew Darżynkiewicz(New York Medical College), Agnieszka Szymczyk(Medical University of Lublin), Dorota Halicka(New York Medical College), Sylwia Chocholska(Medical University of Lublin), Arkadiusz Macheta(Medical University of Lublin), Marek Hus(Medical University of Lublin)
Cited by 59
Related Papers
Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross‐linking agent cisplatin
|Cytometry Part A|2004|197
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Interactions of fluorochrome‐labeled caspase inhibitors with apoptotic cells: A caution in data interpretation
|Cytometry Part A|2003|136
Therapy‐related peripheral neuropathy in multiple myeloma patients
|Hematological Oncology|2014|70